Cargando…
Supramolecular Prodrug Nanovectors for Active Tumor Targeting and Combination Immunotherapy of Colorectal Cancer
Immunotherapy aiming to harness the exquisite power of the immune system has emerged as a crucial part of clinical cancer management. However, only a subset of cancer patients responds to current immunotherapy because of low immunogenicity of the tumor cells and immunosuppressive tumor microenvironm...
Autores principales: | Hu, Xianli, Hou, Bo, Xu, Zhiai, Saeed, Madiha, Sun, Fang, Gao, Zhenmei, Lai, Yi, Zhu, Tong, Zhang, Fan, Zhang, Wen, Yu, Haijun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7175291/ https://www.ncbi.nlm.nih.gov/pubmed/32328426 http://dx.doi.org/10.1002/advs.201903332 |
Ejemplares similares
-
Regulating Glucose Metabolism with Prodrug Nanoparticles for Promoting Photoimmunotherapy of Pancreatic Cancer
por: Sun, Fang, et al.
Publicado: (2021) -
Dual-targeting prodrug nanotheranostics for NIR-Ⅱ fluorescence imaging-guided photo-immunotherapy of glioblastoma
por: Li, Fenglin, et al.
Publicado: (2022) -
Bispecific prodrug nanoparticles circumventing multiple immune resistance mechanisms for promoting cancer immunotherapy
por: Ye, Jiayi, et al.
Publicado: (2022) -
The Landscape of Nanovectors for Modulation in Cancer Immunotherapy
por: Volovat, Simona-Ruxandra, et al.
Publicado: (2022) -
Supramolecular prodrug hydrogelator as an immune booster for checkpoint blocker–based immunotherapy
por: Wang, Feihu, et al.
Publicado: (2020)